Exagen: The Path To Profitability Just Became More Credible (NASDAQ:XGN)
· seekingalpha.com
Exagen's turnaround is translating into results, with operating leverage emerging and profitability within reach. Read why I maintain a Buy rating for XGN stock.
My name is María Fernanda and I'm currently studying an MBA. My inspiration investors are Warren Buffett, Peter Lynch and Terry Smith, so I look for quality co...